EUVIMEDEUVIMED entdecken
Übersichtsarbeit

To Treat or Not to Treat: Ethics of Management of Refractory Status Myoclonus Following Pediatric Anoxic Brain Injury

Alyson K Baker, Jennifer L Griffith

Seminars in Pediatric Neurology · 2023

DOI: 10.1016/j.spen.2023.101033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Pediatric Neurology, 2023. Verfasst von Alyson K Baker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE; Children's Hospital and Medical Center, Omaha, NE. Electronic address: al…. Hauptthemen laut MEDLINE: Myoclonus, Heart Arrest, Hypoxia, Brain, Brain Injuries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of status myoclonus (SM) in a postcardiac arrest patient has historically been thought of as indicative of not only a poor neurologic outcome but of neurologic devastation. In many instances, this may lead clinicians to initiate conversations about withdrawal of life sustaining therapies (WLST) regardless of the time from return of spontaneous circulation (ROSC). Recent studies showing a percentage of patients may make a good recovery has called into question whether a self-fulfilling prophecy has developed where the concern for a poor neurologic outcome leads clinicians to prematurely discuss WLST. The issue is only further complicated by changing terminology, lack of neuro-axis localization, and limited data regarding association with electroencephalogram (EEG) characteristics, all of which could aid in the understanding of the severity of neurologic injury associated with SM. Here we review the initial literature reporting SM as indicative of poor neurologic outcome, the studies that call this into question, the various definitions of SM and related terms as well as data regarding association with EEG backgrounds. We propose that improved prognostication on outcomes results from combining the presence of SM with other clinical variables (eg EEG patterns, MRI findings, and clinical exam). We discuss the ethical implications of using SM as a prognostic tool and its impact on decisions about life-sustaining care in children following cardiac arrest. We advocate for prognostication efforts to be delayed for at least 72 hours following ROSC and thus to treat SM in those early hours and days.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyoclonusHeart ArrestHypoxia, BrainBrain InjuriesHumansChildPrognosis

Autor:innen und Institutionen

  • Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE; Children's Hospital and Medical Center, Omaha, NE. Electronic address: alybaker@childrensomaha.org.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis, MO; Department of Neurology, Washington University School of Medicine, St. Louis, MO.

Zitieren

APA

Baker, A. K., & Griffith, J. L. (2023). To Treat or Not to Treat: Ethics of Management of Refractory Status Myoclonus Following Pediatric Anoxic Brain Injury. Seminars in Pediatric Neurology. https://doi.org/10.1016/j.spen.2023.101033

Vancouver

Baker AK, Griffith JL. To Treat or Not to Treat: Ethics of Management of Refractory Status Myoclonus Following Pediatric Anoxic Brain Injury. Seminars in Pediatric Neurology. 2023. doi:10.1016/j.spen.2023.101033

BibTeX
@article{Baker2023,
  author = {Baker, Alyson K and Griffith, Jennifer L},
  title = {To Treat or Not to Treat: Ethics of Management of Refractory Status Myoclonus Following Pediatric Anoxic Brain Injury},
  journal = {Seminars in Pediatric Neurology},
  year = {2023},
  doi = {10.1016/j.spen.2023.101033}
}
Kostenlos starten →